Skip to main content

Yes: It Bureaucratizes, Politicizes Research

When techniques for sequencing segments of DNA became available, it seemed self-evident that the most valuable material to analyze was the regions that could be associated with a function or a disease. More than 95 percent of the human genome did not seem interesting to explore in detail because it does not code for the kinds of functions that we can recognize, and so it is temporarily called "junk." A few years ago, however, it was proposed that systematic sequencing of the entire human genome

Written byBernard Davis
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00

This human genome program had an unusual origin. It was not initiated by a committee of molecular geneticists dealing with a pressing need, or by the major biomedical funding agency, the National Institutes of Health. Instead, it was advanced by an administrator in the Department of Energy, convinced that with the powerful tools of molecular biology it was now time to introduce centrally administered "big science" into biomedical research.

The idea quick-ly developed strong political appeal. Sequencing the entire human genome was as definite and as highly visible as putting a man on the moon; it promised large benefits for human health and for our understanding of human biology; and it was claimed to be more efficient and cheaper than reaching the goal eventually by piecemeal sequencing. The NIH was initially not supportive, but when the program proved to be inevitable, it became the logical major partner. The HGP has ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Published In

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell
Scientist reviewing cellular and molecular data on a computer in a laboratory.

Building Translation-Ready Biomarkers with Connected Workflows

Danaher Logo

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays